‘Significant opportunity’ in Asia as supply chain integrates, consolidates
INTERVIEW: Hugh Napier | AlmaStone Hugh Napier brings a background in commodities trading and financial services to the emerging industrial hemp sectors, with a mission…
China
Chinese govt may limit licenses in response to stock jumps
The Chinese government has tightened control on industrial hemp licenses after recent sharp fluctuations in share prices of publicly traded companies. China’s National Anti-Drug Committee…
Asian Hemp Summit finds a continent rising fast
Asia is well positioned to embrace hemp in an innovative and unique way, with stakeholders only beginning to capitalize on the rich genetic diversity of…
Early signups have reps from 19 countries headed to Asian Hemp Summit
Delegates from 19 countries around the globe are already signed up for the first-ever Asian Hemp Summit to be held Feb. 1-2, 2019 at the…
More happening in Chinese hemp than meets the eye
The opening of the Chinese hemp market will no doubt be significant for the industry globally. While little is known about the world’s biggest hemp…
SHIV picks up license to publish Indian edition of HempToday
HempToday and Shah Hemp Inno-Ventures (SHIV) will launch HempToday India under a licensing arrangement, the companies have announced. Nepal-based SHIV is a leading voice for…
Asian Summit signs on HempConsult and Hempro as sponsors
Leading global industry players HempConsult GmbH and Hempro International GmbH & Co. KG, both of Germany, have signed on as sponsors of the inaugural Asian…
Benhaim is featured speaker at inaugural Asian Hemp Summit
Paul Benhaim, CEO at Elixinol Global Ltd., is confirmed as among featured speakers at next year’s first Asian Hemp Summit in Nepal. The event is…
Asian edge in the ‘New Green Revolution’: Genetic diversity
In the “New Green Revolution” brought on by the resurgence of Cannabis, Asian hemp, with the most genetic diversity on the planet, has a decided…
Reps from 10 countries will talk CBD at HT’s August biz meet-up
Health care needs to eschew a high-tech approach and go beyond the treatment of symptoms to attack the causes of chronic diseases rooted in current…